SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortec (CRTQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jatin Kadakia who wrote (17)2/25/1997 5:58:00 PM
From: Warren Keschner   of 22
 
Smith-kline will be releasing results on phase 2 results for inflammatory drug
at the end of March or early April. Stock will move based on those
results. They have some other products in the pipeline, but this one is nearest
to possibly being marketed. Technically, the stock has been trading between in
narrow range since 7/94. Any positive news should move this stock materially.
I also feel this is limited downside risk since its cash value is 1.20.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News